Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

BACKGROUND: The incidence of colorectal cancer (CRC) is considered to be the third-highest malignant tumor among all carcinomas. The alterations in cellular bioenergetics (metabolic reprogramming) are associated with several malignant phenotypes in CRC, such as tumor cell proliferation, invasion, me...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaxin, Li, Yimin, Xiao, Qing, Li, Yuanyuan, Peng, Yuqian, Gan, Yaqi, Shu, Guang, Yi, Hanxi, Yin, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531485/
https://www.ncbi.nlm.nih.gov/pubmed/36195841
http://dx.doi.org/10.1186/s12885-022-10126-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531485/
https://www.ncbi.nlm.nih.gov/pubmed/36195841
http://dx.doi.org/10.1186/s12885-022-10126-0

Ejemplares similares